Dr. Michael M. Gottesman has spent nearly four decades as a highly respected scientist at the National Institutes of Health (NIH), conducting important studies on how cancer cells resist destruction by several widely used chemotherapy drugs.
As chief of the laboratory of cell biology at the National Cancer Institute (NCI), Gottesman is the country’s premier researcher on the interaction of cancer and medications. He has developed molecular tools to define the drug-resistance genes found in individual cancers, information that is used to predict a patient’s response to therapy.
{iframe}http://www.washingtonpost.com/politics/federal_government/making-cancer-drugs-more-effective/2013/09/03/15dfb2ba-149a-11e3-a100-66fa8fd9a50c_story.html?wpisrc=nl_fed{/iframe}